Psychopharmacology and Psychiatry Updates

A podcast by Psychopharmacology Institute

Categorie:

213 Episodio

  1. Olanzapine/Samidorphan: Good for Psychosis With Less Weight Gain?

    Pubblicato: 8/12/2023
  2. Melatonin's Impact on Suicidality and Accidents in Adolescents

    Pubblicato: 3/12/2023
  3. Understanding Sleep-Related Eating Disorder (SRED)

    Pubblicato: 28/11/2023
  4. Pimavanserin: A Solution for Psychosis in Parkinson's Disease?

    Pubblicato: 23/11/2023
  5. Current Approaches to Treating Pediatric Bipolar Disorder

    Pubblicato: 18/11/2023
  6. Exploring Pharmacogenomic Testing in MDD

    Pubblicato: 13/11/2023
  7. Broad-Spectrum Micronutrients: A New Frontier in ADHD Treatment

    Pubblicato: 8/11/2023
  8. Predicting Nonadherence in ADHD: A Focus on Side Effects

    Pubblicato: 3/11/2023
  9. How Nutrient Metabolism Influences Mental Health

    Pubblicato: 29/10/2023
  10. Antipsychotics and Substance Use: A Fresh Look at Old Drugs

    Pubblicato: 24/10/2023
  11. The Effect of the Mediterranean Diet on Depression

    Pubblicato: 19/10/2023
  12. Racial Disparities in Pharmacologic Restraints

    Pubblicato: 14/10/2023
  13. Managing Orthostasis in Patients on Clozapine

    Pubblicato: 9/10/2023
  14. Lavender Extract for Anxiety

    Pubblicato: 4/10/2023
  15. Psychopharmacology Insights: Clozapine and Constipation

    Pubblicato: 29/9/2023
  16. Understanding the Cardiovascular Impact of ADHD Medication

    Pubblicato: 24/9/2023
  17. Sialorrhea: A Clozapine Side Effect

    Pubblicato: 19/9/2023
  18. Inflammation and Antidepressants: A New Treatment Frontier?

    Pubblicato: 14/9/2023
  19. Ketamine Therapy: A New Hope for Adolescent Depression?

    Pubblicato: 9/9/2023
  20. Unraveling Nightmares: Exploring REM Sleep Behavior Disorder

    Pubblicato: 4/9/2023

3 / 11

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

Visit the podcast's native language site